News

No link between vasectomy, prostate cancer in U.S. cohort


 

FROM THE JOURNAL OF CLINICAL ONCOLOGY

References

Vasectomy does not appear to be associated with prostate cancer mortality or prostate cancer incidence, according to findings from a large U.S. prospective cohort of men aged 40 years or older.

Prostate cancer mortality was examined in the overall Cancer Prevention Study II (CPS-II) cohort of 363,726 men, including 7,451 who died as a result of prostate cancer between 1982 and 2012, and no association was found with vasectomy (hazard ratio, 1.01).

©alexdans/Thinkstock

Overall and high-grade prostate cancer incidence rates were examined among 66,542 men from the CPS-II Nutrition cohort subgroup, including 9,133 who were diagnosed with prostate cancer between 1991 and 2011, and again no associations were found with vasectomy (HR, 1.02 and 0.91, respectively), Eric J. Jacobs, PhD, and his colleagues at the American Cancer Society report (J Clin Oncol. 2016 Sep 19. doi: 10.1200/JCO.2015.66.2361).

Results were similar after adjusting for years since vasectomy and in analyses restricted to men aged 50 years and older, the investigators noted.

Findings from prior, smaller studies have been conflicting, but the current study – the largest-known study to date to examine the association between vasectomy and prostate cancer, according to the authors – provides “some reassurance that vasectomy is unlikely to meaningfully increase risk of prostate cancer,” they wrote.

The authors reported having no disclosures.

sworcester@frontlinemedcom.com

Recommended Reading

Statins don’t appear to compromise effectiveness of abiraterone
MDedge Family Medicine
Diet, lifestyle factors add up in reducing risk of prostate cancer death
MDedge Family Medicine
Radiotherapy for prostate cancer linked to higher risk of secondary malignancies
MDedge Family Medicine
Trial supports combined androgen suppression, radiotherapy for prostate cancer
MDedge Family Medicine
Large cohort study confirms link between pioglitazone, bladder cancer
MDedge Family Medicine
PSA screens could be cost effective if low-risk cases went untreated
MDedge Family Medicine
NCI: Use of dug wells in New England linked with risk of bladder cancer
MDedge Family Medicine
No OS benefit with tasquinimod in mCRPC
MDedge Family Medicine
Prostate cancer incidence continues to decrease after recommendation against screening
MDedge Family Medicine
New anticancer drugs linked to increased costs, life expectancy
MDedge Family Medicine